Compared to Estimates, Pacira (PCRX) Q1 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Pacira (PCRX) give a sense of how the business performed in the quarter…
18,650€
0,81%
Echtzeit-Aktienkurs Pacira Pharmaceuticals Inc.
Bid:
Ask:
Nachrichten zur Pacira Pharmaceuticals Inc. Aktie
Pacira (PCRX) Lags Q1 Earnings Estimates
Pacira (PCRX) delivered earnings and revenue surprises of -11.67% and 2.12%, respectively, for the quarter ended March 2023. Do the…
Form 8-K Pacira BioSciences, Inc. For: May 03
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Pacira BioSciences Q1 2023 Earnings Preview
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Pacira to Report First Quarter 2023 Financial Results on Wednesday May 3, 2023
TAMPA, Fla., April 26, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will report…
What 6 Analyst Ratings Have To Say About Pacira BioSciences
Latest Ratings for PCRX
DateFirmActionFromTo Feb 2022WedbushMaintainsOutperform Feb 2022HC Wainwright & Co.MaintainsBuy Jan 2022BarclaysMaintainsOverweight
View…
Pacira BioSciences Partners with The Invited Celebrity Classic – a PGA TOUR Champions Event – to Make iovera° The Official Non-Opioid Pain Management Partner
PGA TOUR Champions Golfer, Paul Goydos, Promotes Further Awareness of Non-Opioids with 2023 Partnership PGA TOUR Champions Golfer, Paul Goydos,…
Pacira BioSciences, Inc. Appoints Christopher Young as Chief Manufacturing Officer
TAMPA, Fla., April 19, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in its…
Pacira BioSciences to Participate in Fireside Chat at the 22nd Annual Needham Virtual Healthcare Conference
TAMPA, Fla., April 12, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will…
Why Is Pacira (PCRX) Down 6% Since Last Earnings Report?
Pacira (PCRX) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates for…
Pacira BioSciences: FDA to Review Exparel in Lower Extremity Procedures >PCRX
Pacira BioSciences: FDA to Review Exparel in Lower Extremity Procedures >PCRX...…
Third Circuit Court Upholds Decision to Dismiss Pacira BioSciences, Inc. Lawsuit
TAMPA, Fla., March 27, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX) today announced that the United…
Form 8-K Pacira BioSciences, Inc. For: Mar 18
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Pacira BioSciences to Participate in Fireside Chat at the 2023 Barclays Global Healthcare Conference
TAMPA, Fla., March 08, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will…
Form 10-K Pacira BioSciences, Inc. For: Dec 31
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Pacira (PCRX) Matches Q4 Earnings Estimates
Pacira (PCRX) delivered earnings and revenue surprises of 0% and 1.24%, respectively, for the quarter ended December 2022. Do the…
Pacira BioSciences Q4 2022 Earnings Preview
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Pacira gains as Wedbush initiates at Outperform seeing attractive entry point
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Pacira BioSciences started at outperform with $60 stock price target at Wedbush
Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…
Insiderhandel: Chief Lgl & Compliance Officer verkauft Aktien von Pacira Pharmaceuticals im Wert von 20.917$
Molloy, Anthony - Vorstand - Tag der Transaktion: 2023-01-05...…
Insiderhandel: Chief Lgl & Compliance Officer verkauft Aktien von Pacira Pharmaceuticals im Wert von 6.177$
Molloy, Anthony - Vorstand - Tag der Transaktion: 2023-01-04...…
Pacira BioSciences Reports Preliminary Unaudited Total Revenue for 2022 of $666.8 Million
EXPAREL average daily sales 104% of the prior year for the fourth quarter and 107% of the prior year for…
Form 8-K Pacira BioSciences, Inc. For: Jan 05
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
3 Reasons Growth Investors Will Love Pacira (PCRX)
Pacira (PCRX) could produce exceptional returns because of its solid growth attributes....…